Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease (HORIZON)

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Medivation, Inc.
ClinicalTrials.gov Identifier:
NCT00920946
First received: June 12, 2009
Last updated: April 13, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given
No publications provided by Medivation, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):